Post

Regeneron’s bispecific lymphoma antibody odronextamab wins FDA priority review

The US Food and Drug Administration (FDA) has accepted the priority review of the biologics license application (BLA) for Regeneron …

Cambridge biotech Thymmune wins $37m NIH grant for thymic cell therapies

The US Department of Health and Human Services has awarded $37m in funding to Thymmune Therapeutics to accelerate the startup …

Karuna Therapeutics files for FDA approval for schizophrenia treatment

Karuna Therapeutics has announced the submission of a new drug application (NDA) to the US Food and Drug Administration for …

ModeX wins $168m BARDA contract to develop viral antibody therapies

The US Biomedical Advanced Research and Development Authority (BARDA) has awarded a $168m Project NextGen contract to ModeX Therapeutics to …

Can reforms restore faith in India’s pharma industry after cough syrup scandals?

India is known as the 'pharmacy of the world', producing a substantial quantity of generic drugs globally. However, its lax …